GPC3 and hepatocellular carcinoma: Perhaps GPC-3 is specifically expressed in HCC but not in benign liver diseases, silencing its gene transcription by specific miRNA or anti-GPC-3 antibody could effectively inhibit HCC proliferation via the Wnt/β-catenin pathway [31].